MS 4.350% Fixed Rate Notes 2033 – Key Pricing Terms
Rhea-AI Filing Summary
Morgan Stanley is offering fixed rate notes due December 16, 2033, issued at $1,000 per note with a fixed interest rate of 4.350% per annum. Interest starts accruing on December 18, 2025 and is paid semi-annually on the 16th of June and December, beginning June 16, 2026, using a 30/360 day-count convention. At maturity, investors receive the $1,000 stated principal amount plus any accrued and unpaid interest.
All payments depend on Morgan Stanley’s credit; the notes are unsecured, not bank deposits and not FDIC-insured. The notes will not be listed on any securities exchange, and any secondary market may be limited, with potential resale prices below the issue price. The estimated value on the pricing date is expected to be approximately $978.80 per note, reflecting issuing, selling, structuring and hedging costs and an internal funding rate that is advantageous to the issuer. These factors, along with changes in interest rates and Morgan Stanley’s credit spreads, can adversely affect the market value of the notes before maturity.
Positive
- None.
Negative
- None.
FAQ
What are the key terms of Morgan Stanley (MS) 4.350% fixed rate notes due 2033?
The notes are unsecured debt of Morgan Stanley with a stated principal amount and issue price of $1,000 per note, a fixed interest rate of 4.350% per annum, and a maturity date of December 16, 2033. Interest accrues from December 18, 2025 and is paid semi-annually on the 16th of June and December, starting June 16, 2026.
How and when do the Morgan Stanley fixed rate notes (MS) pay interest?
Interest on the notes is calculated on a 30/360 (Bond Basis) day-count convention at a fixed rate of 4.350% per annum. Payments are made in arrears on the 16th calendar day of each June and December, beginning June 16, 2026. If a payment date is not a business day, payment moves to the next business day without adjustment to the interest amount.
What does an investor receive at maturity on these Morgan Stanley notes?
On the December 16, 2033 maturity date, each note pays the $1,000 stated principal amount plus any accrued and unpaid interest. In the event of an event of default and acceleration, the amount due per note is also the stated principal plus accrued and unpaid interest.
What are the main risks of investing in the Morgan Stanley 2033 fixed rate notes?
Investors are exposed to Morgan Stanley’s credit risk; if the issuer defaults, some or all of the investment may be lost. The notes are unsecured, not insured by the FDIC or any government agency, and will not be listed on any securities exchange, so secondary trading may be limited. Market value can be adversely affected by changes in interest rates, the issuer’s credit ratings or credit spreads, time to maturity and dealer bid-offer spreads.
Why is the estimated value of the Morgan Stanley notes lower than the $1,000 issue price?
Morgan Stanley estimates the value of each note on the pricing date to be approximately $978.80 or within $58.80 of that amount. This reflects the inclusion of issuing, selling, structuring and hedging costs in the $1,000 issue price and the use of an internal funding rate that is likely lower than the issuer’s secondary market credit spreads. These factors make the economic terms less favorable to investors than they otherwise would be.
Will there be a secondary market for the Morgan Stanley fixed rate notes (MS)?
The notes will not be listed on any securities exchange. Morgan Stanley & Co. LLC may, but is not obligated to, make a market and can stop at any time. Any secondary market price will reflect the dealer’s bid/offer spread, Morgan Stanley’s credit spreads, market volatility, time to maturity, hedging costs and other factors, and may be substantially below the original issue price.
How will Morgan Stanley use the proceeds from these 4.350% fixed rate notes?
Morgan Stanley expects to use the proceeds from the sale of the notes for general corporate purposes. For each note issued, the issuer receives $1,000 in aggregate because the hedging counterparty reimburses the cost of the agent’s commissions. The investor bears the costs of issuing, structuring and hedging through the issue price.